Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction|
|Citation:||American Journal of Respiratory and Critical Care Medicine, 2012; 186(7):622-632|
|Publisher:||American Thoracic Society|
|Jemma B. Wilk, Nick R. G. Shrine, Laura R. Loehr, Jing Hua Zhao, Ani Manichaikul, Lorna M. Lopez, Albert Vernon Smith, Susan R. Heckbert, Joanna Smolonska, Wenbo Tang, Daan W. Loth, Ivan Curjuric, Jennie Hui, Michael H. Cho, Jeanne C. Latourelle, Amanda P. Henry, Melinda Aldrich, Per Bakke, Terri H. Beaty, Amy R. Bentley, Ingrid B. Borecki, Guy G. Brusselle, Kristin M. Burkart, Ting-hsu Chen, David Couper, James D. Crapo, Gail Davies, Josée Dupuis, Nora Franceschini, Amund Gulsvik, Dana B. Hancock, Tamara B. Harris, Albert Hofman, Medea Imboden, Alan L. James, Kay-Tee Khaw, Lies Lahousse, Lenore J. Launer, Augusto Litonjua, Yongmei Liu, Kurt K. Lohman, David A. Lomas, Thomas Lumley, Kristin D. Marciante, Wendy L. McArdle, Bernd Meibohm, Alanna C. Morrison, Arthur W. Musk, Richard H. Myers, Kari E. North, Dirkje S. Postma, Bruce M. Psaty, Stephen S. Rich, Fernando Rivadeneira, Thierry Rochat, Jerome I. Rotter, María Soler Artigas, John M. Starr, Andre, G. Uitterlinden, Nicholas J. Wareham, Cisca Wijmenga, Pieter Zanen, Michael A. Province, Edwin K. Silverman, Ian J. Deary, Lyle J. Palmer, Patricia A. Cassano, Vilmundur Gudnason, R. Graham Barr, Ruth J. F. Loos, David P. Strachan, Stephanie J. London, H. Marike Boezen, Nicole Probst-Hensch, Sina A. Gharib, Ian P. Hall, George T. O, Connor, Martin D. Tobin, and Bruno H. Stricker|
|Abstract:||RATIONALE, Genome-wide association studies, GWAS, have identified loci influencing lung function, but fewer genes influencing chronic obstructive pulmonary disease, COPD, are known. OBJECTIVES, Perform meta-analyses of GWAS for airflow obstruction, a key pathophysiologic characteristic of COPD assessed by spirometry, in population-based cohorts examining all participants, ever smokers, never smokers, asthma-free participants, and more severe cases. METHODS, Fifteen cohorts were studied for discovery, affected, unaffected, and a population-based family study and a meta-analysis of case-control studies were used for replication and regional follow-up, cases, control subjects, . Airflow obstruction was defined as FEV, and its ratio to FVC, FEV, FVC, both less than their respective lower limits of normal as determined by published reference equations. MEASUREMENTS AND MAIN RESULTS, The discovery meta-analyses identified one region on chromosome, q, ., meeting genome-wide significance in ever smokers that includes AGPHD, IREB, and CHRNA, CHRNA, genes. The region was also modestly associated among never smokers. Gene expression studies confirmed the presence of CHRNA, in lung, airway smooth muscle, and bronchial epithelial cells. A single-nucleotide polymorphism in HTR, a gene previously related to FEV, FVC, achieved genome-wide statistical significance in combined meta-analysis. Top single-nucleotide polymorphisms in ADAM, RARB, PPAP, B, and ADAMTS, were nominally replicated in the COPD meta-analysis. CONCLUSIONS, These results suggest an important role for the CHRNA, region as a genetic risk factor for airflow obstruction that may be independent of smoking and implicate the HTR, gene in the etiology of airflow obstruction.|
|Keywords:||chronic obstructive pulmonary disease; single-nucleotide polymorphism; genes|
|Appears in Collections:||Translational Health Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.